Search results
Analysis-New Humira rivals likely to hit US market with small discounts in July
Reuters via Yahoo News· 12 months agoAt least four drugmakers are expected to launch new copycat versions of AbbVie's top-selling...
AbbVie's Humira gets a U.S. rival, but costs could stay high
Reuters via Yahoo Finance· 1 year agoU.S. patients will finally get access to cheaper versions of AbbVie Inc’s blockbuster arthritis drug...
Zacks Industry Outlook Highlights Amphastar, Dr. Reddy's and Teva Pharmaceutical
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – May 24, 2023 – Today, Zacks Equity Research discusses Amphastar...
Cheaper competition for Humira is hitting the market, but savings will depend on your insurance
Associated Press via Yahoo News· 12 months agoPatients who take the autoimmune disease treatment Humira may see some price relief when several...
Sandoz launches rival version of AbbVie's arthritis drug Humira
Reuters via Yahoo News· 12 months agoThe Novartis-owned company said its drug, Hyrimoz, will be priced at a 5% discount off Humira’s...
Fresenius launches biosimilar version of AbbVie's Humira at 5% discount
Reuters via Yahoo News· 12 months agoFresenius joins drugmakers Boehringer Ingelheim, Sandoz and Organon, which launched Humira...
Arthritis drug Humira's two-decade reign ends as Amgen launches competing biosimilar
USA TODAY via Yahoo News· 1 year agoDrugmaker Amgen on Tuesday launched a biosimilar to the widely-prescribed Humira, giving consumers...
Cigna to add three Humira biosimilars to drug reimbursement list
Reuters via AOL· 11 months ago(Reuters) -Cigna Group's Express Scripts pharmacy benefits unit will add three biosimilar versions...
Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
Zacks via Yahoo Finance· 10 months agoAbbVie’s ABBV key blockbuster immunology medicine, Humira lost patent protection in the United...
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Reuters via Yahoo News· 9 months ago(Reuters) -Germany's Boehringer Ingelheim on Monday launched an unbranded version of its biosimilar...